Long term prescription of medications such as the following are likely to increase the cause of, or exacerbate the risk of B12 deficiency - the proton pump inhibitors (esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole), famotidine, ranitidine, metformin, glibenclamide, gliclazide, glimepiride, glipizide, sodium valproate, gabapentin, doxycycline, some oral contraceptives
Research peptides referenced on PeptideStack are intended for in-vitro laboratory research only and are not presented as treatments, prescriptions, or instructions for human use
And that precedent is dangerous
Studies in animal models have indicated that BPC-157 research compounds may promote angiogenesis, the formation of new blood vessels, through VEGF-mediated pathways (Chang et al., 2011)